机械通气氧合指数对ARDS患者预后的评估价值:228例回顾性分析
该研究回顾性分析228例接受机械通气的ARDS患者,在保护性通气策略实施后30分钟以压力控制通气进行肺复张(RM),并于机械通气即刻、RM后及6、12、24小时行动脉血气分析计算氧合指数。28天内死亡99例、存活129例,病死率43.4%。存活者RM后及6、12、24小时氧合指数均显著高于非存活者(均P<0.05)。ROC曲线显示RM后氧合指数预测28天预后的AUC为0.688,6、12、24小时氧合指数AUC分别为0.719、0.727、0.754,不同时间点间无显著差异。作者认为机械通气后氧合指数预测价值较高,可考虑用机械通气6小时氧合指数评估ARDS患者预后。
要点
- 228例ARDS患者28天病死率43.4%(死亡99例、存活129例)。
- 存活者RM后及机械通气6、12、24小时氧合指数均显著高于非存活者(均P<0.05)。
- 机械通气6、12、24小时氧合指数预测28天预后的AUC分别为0.719、0.727、0.754,各时间点间无显著差异。
- RM后氧合指数预测28天预后AUC为0.688,截断值80.75 mmHg时敏感度97.7%、特异度42.4%,仅可用于初步判断预后。
- 作者认为可考虑用机械通气6小时氧合指数评估ARDS患者预后。
适用人群与场景
- 2014年2月至2016年6月中国医科大学附属第一医院急诊科收治的228例ARDS患者,均接受机械通气治疗。
处置流程与药物剂量
- 所有患者接受机械通气,并在实施保护性通气策略后30分钟以压力控制通气(PCV)进行肺复张(RM)。
- 于机械通气即刻、RM后及机械通气6、12、24小时行动脉血气分析并计算氧合指数。
研究设计与关键结果
- 回顾性分析,228例ARDS患者,28天内死亡99例、存活129例,病死率43.4%。
- 存活者与非存活者RM后及机械通气6、12、24小时氧合指数均呈持续升高趋势,非存活者显著低于存活者(均P<0.05)。
- 高氧合组(氧合指数≥150 mmHg)与低氧合组(氧合指数<150 mmHg)在机械通气即刻及RM后机械通气时间无显著差异,但高氧合组在机械通气6、12、24小时机械通气时间均显著短于低氧合组(均P<0.01)。
- 通气24小时后,非存活者血肌酐、脑钠肽、乳酸、右心室内径及SOFA评分显著高于存活者,动脉血氧分压、血小板及右心室射血分数显著低于存活者(均P<0.05)。
- 通气24小时后,非存活者呼气末正压、潮气量及分钟通气量显著高于存活者,胸廓静态顺应性显著低于存活者(均P<0.01)。
- RM后氧合指数与机械通气6、12、24小时氧合指数呈正相关(r值分别为0.856、0.765、0.758,均P<0.001)。
- ROC曲线显示RM后氧合指数预测28天预后的AUC为0.688,截断值80.75 mmHg时敏感度97.7%、特异度42.4%,仅可用于初步判断预后;机械通气6、12、24小时氧合指数预测28天存活的AUC分别为0.719、0.727、0.754,截断值分别为171.50、192.14、161.75 mmHg,敏感度分别为69.8%、67.4%、86.0%,特异度分别为78.8%、78.8%、63.6%,不同时间点间无显著差异。
证据类型、等级与局限
- 证据类型:回顾性分析。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为RM后早期氧合指数可初步判断患者预后。
- 作者认为机械通气后氧合指数对ARDS患者28天存活的预测价值较高,可考虑用机械通气6小时氧合指数评估ARDS患者预后。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
OBJECTIVE: To investigate the evaluation value of oxygenation index at different times of mechanical ventilation (MV) on the prognosis of patients with acute respiratory distress syndrome (ARDS).
METHODS: A retrospectively analysis was conducted. A total of 228 patients with ARDS admitted to Department of Emergency of China Medical University Affiliated First Hospital from February 2014 to June 2016 were enrolled. All patients underwent MV treatment, and recruitment maneuver (RM) was performed by pressure-controlled ventilation (PCV) 30 minutes after the implementation of the protective ventilation strategy. Arterial blood gas analysis was performed at MV immediately, after RM and at 6, 12, 24 hours of MV, and oxygenation index was calculated. Vital signs, laboratory data, ultrasonic echocardiography, sequential organ failure assessment (SOFA) score, duration of MV, and ventilator related parameters of patients were collected. The patients were divided into survivors and non-survivors according to the prognosis of 28 days. The survivors were subdivided into high and low oxygenation group (oxygenation index was ≥ 150 mmHg and < 150 mmHg, respectively, 1 mmHg = 0.133 kPa). Differences in clinical indicators between survivors and non-survivors were compared. The correlation between the oxygenation index after RM and the oxygenation index at each time after MV was analyzed by bivariate correlation analysis. Receiver operating characteristic (ROC) curve was plotted to analyze predictive value of oxygenation index measured at different times for the 28-day outcome of patients with ARDS.
RESULTS: Among 228 patients, 99 patients died within 28 days, and 129 survived, with mortality rate of 43.4%. (1) The oxygenation index after RM and at 6, 12, 24 hours after MV in survivors and non-survivors showed a continuously increased tendency, which was significantly lower in non-survivors than that in survivors (all P < 0.05). There was no significant difference in the duration of MV between high oxygenation group and low oxygenation group at MV immediately and after RM, but the duration of MV in high oxygenation group was significantly shorter than that of the low oxygenation group at 6, 12, 24 hour of MV (all P < 0.01). (2) After ventilation for 24 hours, serum creatinine (SCr), brain natriuretic peptide (BNP), lactate (Lac), right ventricular internal diameter, and SOFA score in non-survivors were significantly higher than those of survivors, and arterial partial pressure of oxygen (PaO2), platelet (PLT) and right ventricular ejection fraction (RVEF) were significantly lower than those of survivors (all P < 0.05). (3) After 24 hours ventilation, positive end-expiratory pressure (PEEP), tidal volume (VT), and minute ventilation (VE) in non-survivors were significantly higher than those of survivors, and static compliance of thorax (Cdyn) was significantly lower than that of survivors (all P < 0.01). (4) It was shown by correlation analysis that the oxygenation index after RM was positively correlated with those at 6, 12, 24 hours of MV (r values were 0.856, 0.765, and 0.758, respectively, all P < 0.001). (5) It was shown by ROC curve that the area under the ROC curve (AUC) of the oxygenation index after RM for predicting 28-day prognosis was 0.688. When the cut-off value was 80.75 mmHg, the sensitivity was 97.7%, and the specificity was 42.4%, which could only be used for preliminary judgment of prognosis. The AUC of oxygenation index at 6, 12, 24 hours of MV for 28-day survival of ARDS patients were 0.719, 0.727, 0.754, respectively. When the cut-off values were 171.50, 192.14, and 161.75 mmHg, the sensitivity was 69.8%, 67.4%, 86.0%, and the specificity was 78.8%, 78.8%, and 63.6%, respectively. It indicated that the predictive value was higher, and no significant difference was found among the oxygenation index at different time points.
CONCLUSIONS: The oxygenation index after the early stage of RM can preliminarily determine the prognosis of patients. The predictive value of oxygenation index after MV for 28-day survival of ARDS patients was higher, so the oxygenation index measured at 6 hours of MV may be considered to evaluate the prognosis of patients with ARDS.
参考来源
- Jia Z, Liu X, Liu Z, et al. [Evaluation value of oxygenation index of mechanical ventilation on the prognosis of patients with ARDS: a retrospective analysis with 228 patients]. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2017. PMID: 28459403. doi:10.3760/cma.j.issn.2095-4352.2017.01.010
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。